|
1
|
Senol K, Ozkan MB, Vural S and Tez M: The
role of inflammation in gastric cancer. Adv Exp Med Biol.
816:235–257. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Plummer M, de Martel C, Vignat J, Ferlay
J, Bray F and Franceschi S: Global burden of cancers attributable
to infections in 2012: A synthetic analysis. Lancet Glob Health.
4:e609–e616. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Wang F, Meng W, Wang B and Qiao L:
Helicobacter pylori-induced gastric inflammation and gastric
cancer. Cancer Lett. 345:196–202. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Robinson K, Kaneko K and Andersen LP:
Helicobacter: Inflammation, immunology and vaccines. Helicobacter.
22 (Suppl 1):2017.doi: 10.1111/hel.12406. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shams AZ and Haug U: Strategies for
prevention of gastrointestinal cancers in developing countries: A
systematic review. J Glob Health. 7:0204052017. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Varga MG, Wang T, Cai H, Xiang YB, Gao YT,
Ji BT, Pawlita M, Waterboer T, Zheng W, Shu XO and Epplein M:
Helicobacter pylori blood biomarkers and gastric cancer
survival in China. Cancer Epidemiol Biomarkers Prev. 27:342–344.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Choi WT and Lauwers GY: Patterns of
gastric injury: Beyond Helicobacter pylori. Surg Pathol
Clin. 10:801–822. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mingomataj EC and Bakiri AH: Regulator
versus effector paradigm: Interleukin-10 as indicator of the
switching response. Clin Rev Allergy Immunol. 50:97–113. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Rivas-Ortiz CI, Lopez-Vidal Y,
Arredondo-Hernandez LJR and Castillo-Rojas G: Genetic alterations
in gastric cancer associated with Helicobacter pylori
infection. Front Med (Lausanne). 4:472017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Niu W, Pang Q, Lin T, Wang Z, Zhang J, Tai
M, Zhang L, Zhang L, Gu M, Liu C and Qu K: A Causal role of
genetically elevated circulating interleukin-10 in the development
of digestive cancers: Evidence from mendelian randomization
analysis based on 29,307 subjects. Medicine (Baltimore).
95:e27992016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kindlund B, Sjoling A, Yakkala C, Adamsson
J, Janzon A, Hansson LE, Hermansson M, Janson P, Winqvist O and
Lundin SB: CD4+ regulatory T cells in gastric cancer
mucosa are proliferating and express high levels of IL-10 but
little TGF-β. Gastric Cancer. 20:116–125. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Drennan S, D'Avola A, Gao Y, Weigel C,
Chrysostomou E, Steele AJ, Zenz T, Plass C, Johnson PW, Williams
AP, et al: IL-10 production by CLL cells is enhanced in the anergic
IGHV mutated subset and associates with reduced DNA methylation of
the IL10 locus. Leukemia. 31:1686–1694. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Giacomelli L, Gianni W, Belfiore C,
Gandini O, Repetto L, Filippini A, Frati L, Aglianò AM and
Gazzaniga P: Persistence of epidermal growth factor receptor and
interleukin 10 in blood of colorectal cancer patients after surgery
identifies patients with high risk to relapse. Clin Cancer Res.
9:2678–2682. 2003.PubMed/NCBI
|
|
14
|
Chang WJ, Du Y, Zhao X, Ma LY and Cao GW:
Inflammation-related factors predicting prognosis of gastric
cancer. World J Gastroenterol. 20:4586–4596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ikeguchi M, Hatada T, Yamamoto M, Miyake
T, Matsunaga T, Fukumoto Y, Yamada Y, Fukuda K, Saito H and Tatebe
S: Serum interleukin-6 and −10 levels in patients with gastric
cancer. Gastric Cancer. 12:95–100. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zhao S, Wu D, Wu P, Wang Z and Huang J:
Serum IL-10 predicts worse outcome in cancer patients: A
meta-analysis. PLoS One. 10:e01395982015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shen X, He Z, Li H, Yao C, Zhang Y, He L,
Li S, Huang J and Guo Z: Distinct functional patterns of gene
promoter hypomethylation and hypermethylation in cancer genomes.
PLoS One. 7:e448222012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pedersen KS, Bamlet WR, Oberg AL, de
Andrade M, Matsumoto ME, Tang H, Thibodeau SN, Petersen GM and Wang
L: Leukocyte DNA methylation signature differentiates pancreatic
cancer patients from healthy controls. PLoS One. 6:e182232011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Son KS, Kang HS, Kim SJ, Jung SY, Min SY,
Lee SY, Kim SW, Kwon Y, Lee KS, Shin KH and Ro J: Hypomethylation
of the interleukin-10 gene in breast cancer tissues. Breast.
19:484–488. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Szalmas A, Banati F, Koroknai A, László B,
Fehér E, Salamon D, Gergely L, Minárovits J and Kónya J:
Lineage-specific silencing of human IL-10 gene expression by
promoter methylation in cervical cancer cells. Eur J Cancer.
44:1030–1038. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Mancini M, Veljkovic N, Leo E, Aluigi M,
Borsi E, Galloni C, Iacobucci I, Barbieri E and Santucci MA:
Cytoplasmatic compartmentalization by Bcr-Abl promotes TET2
loss-of-function in chronic myeloid leukemia. J Cell Biochem.
113:2765–2774. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Klug M, Schmidhofer S, Gebhard C,
Andreesen R and Rehli M: 5-Hydroxymethylcytosine is an essential
intermediate of active DNA demethylation processes in primary human
monocytes. Genome Biol. 14:R462013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hassan N, Ali A, Withycombe C, Ahluwalia
M, Al-Nasseri RH, Tonks A and Morris K: TET-2 up-regulation is
associated with the anti-inflammatory action of Vicenin-2.
Cytokine. 108:37–42. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hofmann SR, Moller J, Rauen T, Paul D,
Gahr M, Rösen-Wolff Z, Brenner S and Hedrich CM: Dynamic CpG-DNA
methylation of Il10 and Il19 in CD4+ T lymphocytes and macrophages:
Effects on tissue-specific gene expression. Klin Padiatr.
224:53–60. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Larsson L, Thorbert-Mros S, Rymo L and
Berglundh T: Influence of epigenetic modifications of the
interleukin-10 promoter on IL10 gene expression. Eur J Oral Sci.
120:14–20. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Verschoor CP, McEwen LM, Kohli V, Wolfson
C, Bowdish DM, Raina P, Kobor MS and Balion C: The relation between
DNA methylation patterns and serum cytokine levels in
community-dwelling adults: A preliminary study. BMC Genet.
18:572017. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu D, Xu J, Yu G, Zhang B, Wang H, Wang C,
Ru G, Sun A, Shen L and Wei Q: Expression status of fatty acid
synthase (FAS) but not HER2 is correlated with the differentiation
grade and prognosis of esophageal carcinoma.
Hepatogastroenterology. 60:99–106. 2013.PubMed/NCBI
|
|
28
|
Li J, Chen C, Bi X, Zhou C, Huang T, Ni C,
Yang P, Chen S, Ye M and Duan S: DNA methylation of CMTM3, SSTR2,
and MDFI genes in colorectal cancer. Gene. 630:1–7. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen X, Yang Y, Liu J, Li B, Xu Y, Li C,
Xu Q, Liu G, Chen Y, Ying J and Duan S: NDRG4 hypermethylation is a
potential biomarker for diagnosis and prognosis of gastric cancer
in Chinese population. Oncotarget. 8:8105–8119. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhou C, Pan R, Li B, Huang T, Zhao J, Ying
J and Duan S: GPX3 hypermethylation in gastric cancer and its
prognostic value in patients aged over 60. Future Oncol.
15:1279–1289. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Yang Y, Chen X, Hu H, Jiang Y, Yu H, Dai
J, Mao Y and Duan S: Elevated UMOD methylation level in peripheral
blood is associated with gout risk. Sci Rep. 7:111962017.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Huang Q, Han L, Liu Y, Wang C, Duan D, Lu
N, Wang K, Zhang L, Gu K, Duan S and Mai Y: Elevation of PTPN1
promoter methylation is a significant risk factor of type 2
diabetes in the Chinese population. Exp Ther Med. 14:2976–2982.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ding L, Bailey MH, Porta-Pardo E, Thorsson
V, Colaprico A, Bertrand D, Gibbs DL, Weerasinghe A, Huang KL,
Tokheim C, et al: Perspective on oncogenic processes at the end of
the beginning of cancer genomics. Cell. 173:305–320.e10. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kent WJ, Sugnet CW, Furey TS, Roskin KM,
Pringle TH, Zahler AM and Haussler D: The human genome browser at
UCSC. Genome Res. 12:996–1006. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Moore KW, de Waal Malefyt R, Coffman RL
and O'Garra A: Interleukin-10 and the interleukin-10 receptor. Annu
Rev Immunol. 19:683–765. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rutz S and Ouyang W: Regulation of
interleukin-10 expression. Adv Exp Med Biol. 941:89–116. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Ma YY, He XJ, Wang HJ, Xia YJ, Wang SL, Ye
ZY and Tao HQ: Interaction of coagulation factors and
tumor-associated macrophages mediates migration and invasion of
gastric cancer. Cancer Sci. 102:336–342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Jung M, Weigert A, Tausendschon M, Mora J,
Ören B, Sola A, Hotter G, Muta T and Brüne B:
Interleukin-10-induced neutrophil gelatinase-associated lipocalin
production in macrophages with consequences for tumor growth. Mol
Cell Biol. 32:3938–3948. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Hwang W, Lee CG, Lee C, Verma R, Rudra D,
Park ZY and Im SH: Locus-specific reversible DNA methylation
regulates transient IL-10 expression in Th1 cells. J Immunol.
200:1865–1875. 2018.PubMed/NCBI
|
|
40
|
Bhattacharjee HK, Bansal VK, Nepal B,
Srivastava S, Dinda AK and Misra MC: Is interleukin 10 (IL10)
expression in breast cancer a marker of poor prognosis? Indian J
Surg Oncol. 7:320–325. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Sun J, Lian M, Ma H, Wang R, Ma Z, Wang H,
Zhai J, Meng L, Feng L, Bai Y, et al: Competing endogenous RNA
network analysis of CD274, IL10 and FOXP3 co-expression in
laryngeal squamous cell carcinoma. Mol Med Rep. 17:3859–3869.
2018.PubMed/NCBI
|
|
42
|
Mosser DM and Zhang X: Interleukin-10: New
perspectives on an old cytokine. Immunol Rev. 226:205–218. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mannino MH, Zhu Z, Xiao H, Bai Q,
Wakefield MR and Fang Y: The paradoxical role of IL-10 in immunity
and cancer. Cancer Lett. 367:103–107. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shimazu T, Asada K, Charvat H, Kusano C,
Otake Y, Kakugawa Y, Watanabe H, Gotoda T, Ushijima T and Tsugane
S: Association of gastric cancer risk factors with DNA methylation
levels in gastric mucosa of healthy Japanese: A cross-sectional
study. Carcinogenesis. 36:1291–1298. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Xu D, Qu L, Hu J, Li G, Lv P, Ma D, Guo M
and Chen Y: Transmembrane protein 106A is silenced by promoter
region hypermethylation and suppresses gastric cancer growth by
inducing apoptosis. J Cell Mol Med. 18:1655–1666. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wani M, Afroze D, Makhdoomi M, Hamid I,
Wani B, Bhat G, Wani R and Wani K: Promoter methylation status of
DNA repair gene (hMLH1) in gastric carcinoma patients of the
Kashmir valley. Asian Pac J Cancer Prev. 13:4177–4181. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Hong SH, Kim HG, Chung WB, Kim EY, Lee JY,
Yoon SM, Kwon JG, Sohn YK, Kwak EK and Kim JW: DNA hypermethylation
of tumor-related genes in gastric carcinoma. J Korean Med Sci.
20:236–241. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Yuasa Y, Nagasaki H, Oze I, Akiyama Y,
Yoshida S, Shitara K, Ito S, Hosono S, Watanabe M, Ito H, et al:
Insulin-like growth factor 2 hypomethylation of blood leukocyte DNA
is associated with gastric cancer risk. Int J Cancer.
131:2596–2603. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Poplawski T, Tomaszewska K, Galicki M,
Morawiec Z and Blasiak J: Promoter methylation of cancer-related
genes in gastric carcinoma. Exp Oncol. 30:112–116. 2008.PubMed/NCBI
|
|
50
|
Verma M: The role of epigenomics in the
study of cancer biomarkers and in the development of diagnostic
tools. Adv Exp Med Biol. 867:59–80. 2015. View Article : Google Scholar : PubMed/NCBI
|
